You can learn more about our research and development through scientific publications and presentations from the Aeglea team and our collaborators.

Select a Program

November 2021

Diagnosis of Arginase 1 Deficiency in a Patient With Cerebral Palsy

November 2021

Diagnosis and Long Term Treatment of Arginase 1 Deficiency

November 2021

Arginine: The Key Driver of Pathophysiology and Progression in Arginase 1 Deficiency

November 2021

Patient Characteristics in the Pivotal Phase 3 PEACE Trial of Pegzilarginase Human Enzyme Therapy for Arginase 1 Deficiency

November 2021

Management and Progression of Arginase 1 Deficiency Over 2 Decades of Follow Up

November 2021

Arginase 1 Deficiency (ARG1-D) Presenting With Clotting Abnormalities

September 2021

July 2021

Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency

January 2021

Arginase 1 Deficiency (ARG1-D): A Systematic Literature Review

October 2020

Development of a Novel Human Engineered Enzyme (ACN00177) for the Treatment of Homocystinuria

Get In Touch With Us